Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DEFLAZACORT vs DELORAZEPAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DEFLAZACORT vs DELORAZEPAM: Safety Overview

Metric DEFLAZACORT DELORAZEPAM
Total FAERS Reports 3,831 1,744
Deaths Reported 149 106
Death Rate 3.9% 6.1%
Hospitalizations 592 999
Average Patient Age 25.7 yrs 44.9 yrs
% Female Patients 15.1% 63.9%
FDA Approval Date Apr 25, 2024 N/A
Manufacturer Cranbury Pharmaceuticals, LLC N/A
Route ORAL N/A
Marketing Status Prescription N/A